Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,808.12
-1.74(-0.03%)
Dow 30
42,114.40
-259.96(-0.61%)
Nasdaq
18,518.61
+103.12(+0.56%)
Russell 2000
2,207.99
-10.93(-0.49%)
Crude Oil
71.69
+1.50(+2.14%)
Gold
2,760.80
+11.90(+0.43%)

Ekso Bionics Holdings, Inc. (EKSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

1.0400

+0.0200

(+1.96%)

At close: 04:00PM EDT

1.0599

+0.02

(+1.91%)

After hours:

07:49PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	22.41M
Enterprise Value	23.21M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.92
Price/Book (mrq)	1.86
Enterprise Value/Revenue	1.28
Enterprise Value/EBITDA	0.46

Trading Information

Stock Price History

Beta (5Y Monthly)	1.46
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	3.1290
52 Week Low ³	0.8270
50-Day Moving Average ³	1.0955
200-Day Moving Average ³	1.3544

Share Statistics

Avg Vol (3 month) ³	86.74k
Avg Vol (10 day) ³	40.2k
Shares Outstanding ⁵	21.54M
Implied Shares Outstanding ⁶	N/A
Float ⁸	16.34M
% Held by Insiders ¹	8.06%
% Held by Institutions ¹	14.62%
Shares Short (Oct 15, 2024) ⁴	141.38k
Short Ratio (Oct 15, 2024) ⁴	2.82
Short % of Float (Oct 15, 2024) ⁴	0.67%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	0.66%
Shares Short (prior month Sep 13, 2024) ⁴	193.55k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	Mar 25, 2020
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:15
Last Split Date ³	Mar 25, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-68.41%
Operating Margin (ttm)	-47.17%

Management Effectiveness

Return on Assets (ttm)	-24.54%
Return on Equity (ttm)	-83.20%

Income Statement

Revenue (ttm)	18.16M
Revenue Per Share (ttm)	1.13
Quarterly Revenue Growth (yoy)	5.30%
Gross Profit (ttm)	N/A
EBITDA	-10.31M
Net Income Avi to Common (ttm)	-12.42M
Diluted EPS (ttm)	-0.7900
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	5.88M
Total Cash Per Share (mrq)	0.32
Total Debt (mrq)	6.69M
Total Debt/Equity (mrq)	55.49
Current Ratio (mrq)	2.42
Book Value Per Share (mrq)	0.65

Cash Flow Statement

Operating Cash Flow (ttm)	-11.07M
Levered Free Cash Flow (ttm)	-6.36M